N6-methyladenosine reader YTHDF3 contributes to the aerobic glycolysis of osteosarcoma through stabilizing PGK1 stability
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00432-022-04337-y.pdf
Reference23 articles.
1. An Y, Duan H (2022) The role of m6A RNA methylation in cancer metabolism. Mol Cancer 21:14. https://doi.org/10.1186/s12943-022-01500-4
2. Dang Q, Shao B, Zhou Q, Chen C, Guo Y, Wang G et al (2021) RNA N (6)-methyladenosine in cancer metastasis: roles, mechanisms, and applications. Front Oncol 11:681781. https://doi.org/10.3389/fonc.2021.681781
3. Fang R, Ye L, Shi H (2021) Understanding the roles of N(6)-methyladenosine writers, readers and erasers in breast cancer. Neoplasia (new York, NY) 23:551–560. https://doi.org/10.1016/j.neo.2021.04.002
4. Fu Q, Yu Z (2020) Phosphoglycerate kinase 1 (PGK1) in cancer: a promising target for diagnosis and therapy. Life Sci 256:117863. https://doi.org/10.1016/j.lfs.2020.117863
5. Hu Y, Zhao X (2021) Role of m6A in osteoporosis, arthritis and osteosarcoma (review). Exp Ther Med 22:926. https://doi.org/10.3892/etm.2021.10358
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. USP22 as a key regulator of glycolysis pathway in osteosarcoma: insights from bioinformatics and experimental approaches;PeerJ;2024-05-20
2. Transcriptional regulation and post-translational modifications in the glycolytic pathway for targeted cancer therapy;Acta Pharmacologica Sinica;2024-04-15
3. Targeting RNA modifications with pharmacological agents: New frontiers in cancer therapy;Cancer Medicine;2024-03-28
4. RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy;Signal Transduction and Targeted Therapy;2024-03-27
5. Phosphoglycerate Kinase 1: An Effective Therapeutic Target in Cancer;Frontiers in Bioscience-Landmark;2024-03-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3